Biomerica, Inc.
BMRA
$2.71
-$0.08-2.87%
NASDAQ
| 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -11.31% | -1.88% | 5.05% | 1.40% | 1.72% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -11.31% | -1.88% | 5.05% | 1.40% | 1.72% |
| Cost of Revenue | -15.41% | 0.10% | 2.61% | 7.93% | 11.58% |
| Gross Profit | 31.13% | -17.60% | 23.99% | -32.62% | -46.88% |
| SG&A Expenses | -19.20% | -15.88% | -15.25% | -4.38% | 1.23% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -18.67% | -11.33% | -10.79% | -3.05% | 1.80% |
| Operating Income | 24.89% | 19.36% | 23.62% | 6.92% | -1.86% |
| Income Before Tax | 40.48% | 16.26% | 23.09% | 6.81% | -0.18% |
| Income Tax Expenses | -95.65% | -95.24% | -91.67% | -84.81% | -68.06% |
| Earnings from Continuing Operations | 40.68% | 16.81% | 23.61% | 7.83% | 0.61% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 40.68% | 16.81% | 23.61% | 7.83% | 0.61% |
| EBIT | 24.89% | 19.36% | 23.62% | 6.92% | -1.86% |
| EBITDA | 25.28% | 19.71% | 24.03% | 7.17% | -1.81% |
| EPS Basic | 44.45% | 20.70% | 26.44% | 14.24% | 12.50% |
| Normalized Basic EPS | 44.25% | 20.17% | 25.95% | 13.26% | 11.81% |
| EPS Diluted | 42.43% | 19.06% | 25.56% | 13.47% | 12.69% |
| Normalized Diluted EPS | 44.25% | 20.17% | 25.95% | 13.26% | 11.81% |
| Average Basic Shares Outstanding | 11.54% | 5.18% | 4.34% | 6.10% | 11.52% |
| Average Diluted Shares Outstanding | 11.54% | 5.18% | 4.34% | 6.10% | 11.52% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |